News

Elinogrel has shown potential to offer clinical improvements over current anti-clotting medications in helping patients avoid heart attacks and strokes, the company said.   Under terms of the

The Phase I double-blind, placebo-controlled trial enrolled 20 healthy male and female subjects in sequential, dose-escalating cohorts. Subjects received once-daily oral doses of either 90mg or 150mg of

The primary aim of the study was to determine the ability of its proprietary OvaCalc algorithm to estimate the risk of malignancy in pre and postmenopausal women who

Coartem dispersible is the result of a public-private collaboration between Novartis and the nonprofit Medicines for Malaria Venture (MMV), Novartis said. According to the company, Coartem Dispersible tablets

According to Expression Analysis, the Geneblitz unit offers molecular services to pharmaceutical companies, governmental agencies, universities and research institutes. The partnership will give Expression Analysis access to these

Through a series of cash payments and equity investments under a previously announced collaborative agreement, Vical has received $17.6 million to date of the $22.6 million total committed

Cytel said that AstraZeneca’s increased use of East also features automated data transfer between its clinical data system (CDS) and East’s trial monitoring component. By eliminating manual data

Beginning in North America and through its direct sales force, Zila now markets ViziLite Plus in all 50 states of the US, as well as Puerto Rico and

The offering is expected to close on February 19, 2009. On February 12, 2009, the last reported sales price of Geron common stock on the Nasdaq global market